Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.
BACKGROUND
Chronic obstructive pulmonary disease (COPD) is predicted to become a major cause of death worldwide. Studies on the variability in the estimates of key epidemiological parameters of COPD may contribute to better assessment of the burden of this disease and to helpful guidance for future research and public policies. In the present study, we examined differences in the main epidemiological characteristics of COPD derived from studies across countries of the European Union, focusing on prevalence, severity, frequency of exacerbations and mortality, as well as on differences between the studies' methods.


METHODS
This systematic review was based on a search for the relevant literature in the Science Citation Index database via the Web of Science and on COPD mortality rates issued from national statistics. Analysis was finally based on 65 articles and Eurostat COPD mortality data for 21 European countries.


RESULTS
Epidemiological characteristics of COPD varied widely from country to country. For example, prevalence estimates ranged between 2.1% and 26.1%, depending on the country, the age group and the methods used. Likewise, COPD mortality rates ranged from 7.2 to 36.1 per 10(5) inhabitants. The methods used to estimate these epidemiological parameters were highly variable in terms of the definition of COPD, severity scales, methods of investigation and target populations. Nevertheless, to a large extent, several recent international guidelines or research initiatives, such as GOLD, BOLD or PLATINO, have boosted a substantial standardization of methodology in data collection and have resulted in the availability of more comparable epidemiological estimates across countries. On the basis of such standardization, severity estimates as well as prevalence estimates present much less variation across countries. The contribution of these recent guidelines and initiatives is outlined, as are the problems remaining in arriving at more accurate COPD epidemiological estimates across European countries.


CONCLUSIONS
The accuracy of COPD epidemiological parameters is important for guiding decision making with regard to preventive measures, interventions and patient management in various health care systems. Therefore, the recent initiatives for standardizing data collection should be enhanced to result in COPD epidemiological estimates of improved quality. Moreover, establishing international guidelines for reporting research on COPD may also constitute a major contribution.
INSERM, U707, F-75012 Paris, France. kokuvi.atsou@u707.jussieu.fr
Kokuvi
K
Atsou
Christos
C
Chouaid
Gilles
G
Hejblum
D018450:Disease Progression; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D012720:Severity of Illness Index
Pulm Pharmacol Ther. 2002;15(4):353-5
12220939
Presse Med. 2005 Dec 3;34(21):1617-22
16327699
Thorax. 2003 May;58(5):399-404
12728159
Respiration. 2005 May-Jun;72(3):270-7
15942296
Arch Bronconeumol. 1998 Jan;34(1):23-7
9580182
Chest. 2003 Aug;124(2):459-67
12907529
Lancet. 2007 Sep 1;370(9589):741-50
17765523
Respir Med. 2009 Apr;103(4):582-8
19103479
Thorax. 1991 Dec;46(12):863-70
1792631
N Engl J Med. 2008 Oct 9;359(15):1543-54
18836213
Value Health. 2004 Mar-Apr;7(2):153-67
15164805
Arch Bronconeumol. 1994 Mar;30(3):149-52
8186908
Chest. 2002 Dec;122(6):1994-2002
12475838
Respirology. 2005 Nov;10(5):594-602
16268912
Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26
17916806
Eur Respir J. 2008 Jun;31(6):1227-33
18216058
Eur Respir J. 2003 Dec;22(6):869
14680068
Am J Respir Crit Care Med. 2006 Apr 15;173(8):871-6
16456141
Respir Res. 2009 Jul 22;10:69
19624838
Chest. 2000 May;117(5 Suppl 2):354S-9S
10843976
Thorax. 1999 Jun;54(6):501-5
10335003
Eur Respir J. 1995 Aug;8(8):1398-420
7489808
Eur Respir J. 2001 Jul;18(1):85-92
11510810
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
17507545
Prim Care Respir J. 2006 Feb;15(1):48-57
16701758
Eur Respir J. 2002 Oct;20(4):806-12
12412668
Eur Respir J. 1991 Mar;4(3):257-66
1864340
Thorax. 2000 Sep;55(9):789-94
10950900
Arch Bronconeumol. 1999 Mar;35(3):122-8
10216744
Respir Med. 2002 Sep;96(9):700-8
12243316
Int J Epidemiol. 1999 Aug;28(4):717-22
10480701
Eur Respir J. 2003 Sep;22(3):413-7
14516128
Eur Respir J. 2004 Jun;23(6):932-46
15219010
Respir Res. 2008 Nov 13;9:73
19014549
Respir Med. 2004 Feb;98(2):178-83
14971883
Lancet. 2003 Feb 8;361(9356):449-56
12583942
Scand J Prim Health Care. 2001 Mar;19(1):54-7
11303549
Respir Med. 2006 Jan;100(1):83-6
15894477
Thorax. 2003 May;58(5):388-93
12728157
Eur Respir J Suppl. 2003 Sep;43:1s-44s
14582902
Thorax. 1997 Dec;52 Suppl 5:S1-28
9474238
Thorax. 2005 Nov;60(11):925-31
16055622
Respir Med. 2010 Apr;104(4):550-6
19931443
Chest. 2006 Aug;130(2):318-25
16899828
Value Health. 2004 Mar-Apr;7(2):168-74
15164806
BMJ. 2000 May 13;320(7245):1297-303
10807619
Thorax. 2008 Feb;63(2):122-8
17702790
Respiration. 2003 Jan-Feb;70(1):67-75
12584394
Am J Respir Crit Care Med. 2000 May;161(5):1608-13
10806163
Respir Med. 2006 Feb;100(2):264-72
15975774
Chest. 2004 Mar;125(3):892-900
15006947
Eur J Epidemiol. 2005;20(5):443-53
16080593
Respir Med. 2009 Apr;103(4):542-51
19138505
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77-121
7582322
JAMA. 2005 Sep 14;294(10):1255-9
16160134
Am J Respir Crit Care Med. 2001 Aug 15;164(4):590-6
11520721
Thorax. 2009 Oct;64(10):863-8
19553233
Respir Res. 2006 Aug 16;7:109
16914029
Chest. 2009 Feb;135(2):368-377
19201711
Thorax. 1996 Feb;51(2):164-8
8711649
PLoS Med. 2006 Nov;3(11):e442
17132052
Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47
18723437
Respir Med. 2000 Apr;94(4):356-63
10845434
Thorax. 2004 Feb;59(2):120-5
14760151
Thorax. 2008 May;63(5):402-7
18234906
COPD. 2008 Dec;5(6):347-52
19353348
Thorax. 2009 Nov;64(11):956-62
19736179
Respir Med. 1998 Dec;92(12):1337-45
10197227
Lancet. 2005 Nov 26;366(9500):1875-81
16310554
Thorax. 2006 Dec;61(12):1043-7
17040932
Chest. 2000 Oct;118(4):981-9
11035667
Eur Respir J. 2003 Dec;22(6):931-6
14680081
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1189-95
19797160
Natl Vital Stat Rep. 2001 May 18;49(2):1-32
11381674
Eur Respir J. 2004 Feb;23(2):241-9
14979498
Lancet. 1997 May 24;349(9064):1498-504
9167458
Eur Respir J. 2006 Mar;27(3):547-55
16507855
Chest. 2000 May;117(5 Suppl 2):339S-45S
10843974
Thorax. 2003 Aug;58(8):654-8
12885977
Int J Clin Pract. 2009 Jan;63(1):87-97
19125996
Eur Respir J. 2003 Jan;21(1):68-73
12570111
Chest. 2002 May;121(5):1441-8
12006426
Int J Tuberc Lung Dis. 2006 May;10(5):490-8
16704029
Lancet. 2009 Aug 29;374(9691):704-11
19716962
Rev Mal Respir. 2005 Sep;22(4):696-704
16294191
Chest. 2007 Jan;131(1):29-36
17218553
Prim Care Respir J. 2006 Dec;15(6):346-53
17064963
Chest. 2000 Feb;117(2 Suppl):1S-4S
10673465